Telisotuzumab Vedotin

Item number	Size	Datasheet	Manual	SDS	Delivery time	Price
BPS-82922-1	1 mg	-	-	-	3 - 15 business days*	805.00€
BPS-82922-2	5 mg	-	-	-	3 - 15 business days*	1,760.00€
BPS-82922-3	10 mg	-	-	-	3 - 15 business days*	2,710.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Telisotuzumab vedotin (ABBV-399) is an antibody-drug conjugate (ADCs) targeting c-Met.... more

Close menu

Product information "Telisotuzumab Vedotin"

Telisotuzumab vedotin (ABBV-399) is an antibody-drug conjugate (ADCs) targeting c-Met. Telisotuzumab vedotin consists of Monomethyl Auristatin E (MMAE), Telisotuzumab antibody and a cleavable mc-val-cit-PABC type linker. Telisotuzumab vedotin can be used to study non-small cell lung cancer expressing c-Met protein1,2.

Keywords:	Anti-MET, Anti-SF receptor, EC=2.7.10.1, Anti-HGF receptor, Anti-HGF/SF receptor, Anti-Proto-oncogene c-Met, Anti-Scatter factor receptor, Anti-Tyrosine-protein kinase Met, Anti-Hepatocyte growth factor receptor,
Supplier:	BPS Bioscience
Supplier-Nr:	82922

Properties

Application:	Cancer therapy target studies
Conjugate:	No
Species reactivity:	human
MW:	~145 kD
Format:	Solution

Database Information

CAS :	1714088-51-3\| Matching products
KEGG ID :	K05099 \| Matching products
UniProt ID :	P08581 \| Matching products
Gene ID :	GeneID 4233 \| Matching products

Handling & Safety

Storage:	-80°C (protect from light)
Shipping:	-80°C (International: -80°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

View product citations for antibody 82922 on CiteAb

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Telisotuzumab Vedotin"

Write a review